190 related articles for article (PubMed ID: 21791594)
1. In vivo ocular fluorophotometry: delivery of fluoresceinated dextrans via transscleral diffusion in rabbits.
Berezovsky DE; Patel SR; McCarey BE; Edelhauser HF
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7038-45. PubMed ID: 21791594
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of intraocular drug delivery by periocular injections using ocular fluorophotometry.
Ghate D; Brooks W; McCarey BE; Edelhauser HF
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2230-7. PubMed ID: 17460284
[TBL] [Abstract][Full Text] [Related]
3. Suprachoroidal delivery in a rabbit ex vivo eye model: influence of drug properties, regional differences in delivery, and comparison with intravitreal and intracameral routes.
Kadam RS; Williams J; Tyagi P; Edelhauser HF; Kompella UB
Mol Vis; 2013; 19():1198-210. PubMed ID: 23734089
[TBL] [Abstract][Full Text] [Related]
4. Comparison of suprachoroidal drug delivery with subconjunctival and intravitreal routes using noninvasive fluorophotometry.
Tyagi P; Kadam RS; Kompella UB
PLoS One; 2012; 7(10):e48188. PubMed ID: 23118950
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of intraocular drug delivery of Oregon green 488-labeled triamcinolone by subtenon injection using ocular fluorophotometry in rabbit eyes.
Lee SJ; Kim ES; Geroski DH; McCarey BE; Edelhauser HF
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4506-14. PubMed ID: 18503001
[TBL] [Abstract][Full Text] [Related]
6. Effect of benzalkonium chloride on transscleral drug delivery.
Okabe K; Kimura H; Okabe J; Kato A; Shimizu H; Ueda T; Shimada S; Ogura Y
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):703-8. PubMed ID: 15671302
[TBL] [Abstract][Full Text] [Related]
7. Delivery from episcleral exoplants.
Pontes de Carvalho RA; Krausse ML; Murphree AL; Schmitt EE; Campochiaro PA; Maumenee IH
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4532-9. PubMed ID: 17003449
[TBL] [Abstract][Full Text] [Related]
8. Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity.
Pitkänen L; Ranta VP; Moilanen H; Urtti A
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):641-6. PubMed ID: 15671294
[TBL] [Abstract][Full Text] [Related]
9. Clearance Kinetics and Clearance Routes of Molecules From the Suprachoroidal Space After Microneedle Injection.
Chiang B; Wang K; Ethier CR; Prausnitz MR
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):545-554. PubMed ID: 28125841
[TBL] [Abstract][Full Text] [Related]
10. Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye.
Patel SR; Berezovsky DE; McCarey BE; Zarnitsyn V; Edelhauser HF; Prausnitz MR
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4433-41. PubMed ID: 22669719
[TBL] [Abstract][Full Text] [Related]
11. Effects of vitreous liquefaction on the intravitreal distribution of sodium fluorescein, fluorescein dextran, and fluorescent microparticles.
Tan LE; Orilla W; Hughes PM; Tsai S; Burke JA; Wilson CG
Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):1111-8. PubMed ID: 20881289
[TBL] [Abstract][Full Text] [Related]
12. [Delivery of macromolecular drugs to the vitreous and its peripheral tissues].
Morita Y; Saino H; Tojo K
Nihon Rinsho; 1998 Mar; 56(3):628-31. PubMed ID: 9549347
[TBL] [Abstract][Full Text] [Related]
13. Pulsed Ultrasound-Mediated Enhancement on Transscleral and Transconjunctival Fluorescein Sodium Delivery to Rabbit Eye
You S; Zhou H; Yang S; Wu S; Chen X; Zhang R; Chen W; Wang H; Mo X
J Ocul Pharmacol Ther; 2023 Mar; 39(2):175-184. PubMed ID: 36930765
[No Abstract] [Full Text] [Related]
14. Effect of intraocular pressure (IOP) and choroidal circulation on controlled episcleral drug delivery to retina/vitreous.
Li J; Lan B; Li X; Sun S; Lu P; Cheng L
J Control Release; 2016 Dec; 243():78-85. PubMed ID: 27717742
[TBL] [Abstract][Full Text] [Related]
15. Diffusion of high molecular weight compounds through sclera.
Ambati J; Canakis CS; Miller JW; Gragoudas ES; Edwards A; Weissgold DJ; Kim I; Delori FC; Adamis AP
Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1181-5. PubMed ID: 10752958
[TBL] [Abstract][Full Text] [Related]
16. Injection site and pharmacokinetics after intravitreal injection of immunoglobulin G.
Miura Y; Uematsu M; Teshima M; Suzuma K; Kumagami T; Sasaki H; Kitaoka T
J Ocul Pharmacol Ther; 2011 Feb; 27(1):35-41. PubMed ID: 21182428
[TBL] [Abstract][Full Text] [Related]
17. A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide.
Robinson MR; Lee SS; Kim H; Kim S; Lutz RJ; Galban C; Bungay PM; Yuan P; Wang NS; Kim J; Csaky KG
Exp Eye Res; 2006 Mar; 82(3):479-87. PubMed ID: 16168412
[TBL] [Abstract][Full Text] [Related]
18. Ocular tissue distribution of betamethasone after anterior-episcleral, posterior-episcleral, and anterior-intrascleral placement of nonbiodegradable implants.
Okabe K; Kimura H; Okabe J; Ogura Y
Retina; 2007; 27(6):770-7. PubMed ID: 17621189
[TBL] [Abstract][Full Text] [Related]
19. The influence of intraocular pressure on the transscleral diffusion of high-molecular-weight compounds.
Cruysberg LP; Nuijts RM; Geroski DH; Gilbert JA; Hendrikse F; Edelhauser HF
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3790-4. PubMed ID: 16186364
[TBL] [Abstract][Full Text] [Related]
20. Distribution of particles, small molecules and polymeric formulation excipients in the suprachoroidal space after microneedle injection.
Chiang B; Venugopal N; Edelhauser HF; Prausnitz MR
Exp Eye Res; 2016 Dec; 153():101-109. PubMed ID: 27742547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
